Skip to content

Clinical trials

Phase 1 Multiple Myeloma trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Phase: Phase 1 Country / region: Denmark Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20121
20141
20151
20161
20171
20191
20202
20211
20221
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting3
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genentech, Inc.4
AbbVie1
Anaveon AG1
BioInvent International AB1
GlycoMimetics Incorporated1
Henrik Gregersen1
Hoffmann-La Roche1
Janssen Research & Development, LLC1
Karyopharm Therapeutics Inc1
Lene Meldgaard Knudsen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma14
Neoplasms2
Disease1
Hematologic Diseases1
Hematologic Neoplasms1
Leukemia1
Leukemia, Lymphocytic, Chronic, B-Cell1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive1
Lymphoma, B-Cell1
Lymphoma, Non-Hodgkin1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.